tnx-102 sl

  1. M

    Trial Report Tonix's Long COVID Drug Fails to Meet Midstage Trial Goal

    (Reuters) - Tonix Pharmaceuticals Holding Corp said on Tuesday its experimental drug failed to meet the primary goal in a mid-stage study for management of widespread muscle pain and tenderness associated with long COVID-19. Shares of the company were down 12% in premarket trading. The...
Back
Top Bottom